IP Library Granted Patent US 11,660,322
Granted Patent B2
US 11,660,322 · App. 15/573,601 · Granted May 30, 2023

Dietary supplement

Inventors: Sophie Moille (Evian-les-Bains, FR); Irma Silva Zolezzi (Carrouge, CH); Edwin Alberto Habeych Narvaez (Lausanne, CH); Nicola Galaffu (Omex, FR); Bertrand Bourqui (Murist, CH); Sara Colombo Mottaz (La Conversion, CH)
Assignee: Societe des Produits Nestle S.A.
A61K35/747A23L33/135A23L33/16A23L33/40A61K9/0053A61K9/0095A61K9/107A61K9/14A61K9/145A61K33/26A61K33/42A61K35/741A61P3/02A61P3/10A61P7/06A23V2002/00A23Y2220/73A23Y2300/49A23Y2300/55
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,660,322
App. No.
15/573,601
Granted
May 30, 2023
Kind
B2
Abstract

An oral composition comprising at least one probiotic bacteria selected from the genera: Lactobacillus, Bifidobacterium , and Bacillus , and ferric pyrophosphate.

Claims (5)

1. A method for treating or reducing an incidence of and/or a severity of at least one condition selected from the group consisting of gestational diabetes, iron deficiency, and anaemia in a female subject in need thereof, the method comprising administering to the female subject in need thereof a composition comprising ferric pyrophosphate and a probiotic bacteria selected from the genera consisting of: Lactobacillus rhamnosus CGMCC 1.3724 and Bifidobacterium lactis CNCM I-3446, the female subject in need thereof is at least one of pregnant, lactating, or prior to pregnancy, and the ferric pyrophosphate has a particle size distribution D 90 of 200 microns or less.

2. The method of claim 1 , wherein composition comprising the ferric pyrophosphate is an emulsion comprising a fatty acid ester.

3. The method of claim 2 , wherein the ferric pyrophosphate has a particle size distribution D 97 of 25 microns or less.

4. The method of claim 1 , wherein the probiotic bacteria is Lactobacillus rhamnosus CGMCC 1.3724.

5. The method of claim 1 , wherein the composition is administered to the female subject during at least one month prior to pregnancy and later for at least one month during pregnancy.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0001 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0165 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ENGLISH TRANSLATION TO SHOW THE FULL AND CORRECT NEW NAME IN SECTION 51. PREVIOUSLY RECORDED AT REEL: 049391 FRAME: 0756. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Jun 13, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049853/0398 →
MERGER Recorded Jun 6, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049391/0756 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2018
From: MOILLE, SOPHIE; SILVA ZOLEZZI, IRMA; HABEYCH NARVAEZ, EDWIN ALBERTO; GALAFFU, NICOLA; BOURQUI, BERTRAND; COLOMBO MOTTAZ, SARA
To: NESTEC S.A.
Reel/Frame 045356/0347 →
Priority Claims (1)
EP 15171552 · Jun 11, 2015 · regional
Continuity (1)
Related Publication 20180133267A1 · May 17, 2018